The Brief Case: Invasive Ceftriaxone-Resistant Nontyphoidal Salmonella and Antimicrobial Susceptibility Testing Considerations
Journal of Clinical Microbiology · 23.05.2023 · 61 (5)
DOI: 10.1128/jcm.00750-22 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Microbiology, erschienen am 23.05.2023. Verfasst von Lili Tao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA. Hauptthemen laut MEDLINE: Ceftriaxone, Salmonella. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
A 10-year-old male with a history of congenital heart disease and heart transplantation 3 years prior presented with the chief complaint of diarrhea.The patient reported having up to 4 to 5 episodes of watery, nonbloody stools daily for the last 3 weeks accompanied with fatigue and loss of appetite and oral intake.He had no recent travel history and no dietary risk factors, such as ingestion of unpasteurized foods.He was afebrile and denied significant abdominal pain during the exam but pain with urination.Laboratory work at presentation was significant for an elevated creatinine level of 4.49 mg/dL (baseline, 0.7 to 0.8 mg/mL), sodium level of 129 mmol/L, and bicarbonate level of 12 mmol/L.His peripheral white blood cell count was 2.7 Â 10 3 /mL with 60.4% neutrophils.Urine displayed 16 white blood cells per high-power field and grew .100,000CFU of Escherichia coli.A BioFire gastrointestinal pathogen panel (bioMérieux, Salt Lake City, UT) ordered the day after presentation was positive for Salmonella and sapovirus.At the time of admission, the patient had been on an immunosuppression regimen of tacrolimus and mycophenolate.However, these medications were paused at admission given the presence of acute kidney injury from dehydration.The patient was started on oral ciprofloxacin at 10 mg/kg of body weight twice a day intravenously (i.v.) for his urinary tract infection and gastroenteritis.Blood cultures were collected at the time of presentation and incubated in a Bactec FX instrument (BD, Sparks, MD).Gram-negative rods were isolated from the Plus aerobic bottle after 16 h of incubation, and antimicrobials were broadened to ceftriaxone (50 mg/kg every 24 h i.v.).An ePlex BCID-GN panel (GenMark, Carlsbad, CA) was performed and was positive for Salmonella sp. and the CTX-M antimicrobial resistance gene.Antibiotic treatment was escalated to meropenem (20 mg/kg every 8 h i.v.).Stool cultures grew Salmonella.MIC testing was performed on Salmonella isolated from blood and stool cultures by the Phoenix NM-306 panel (BD, Sparks MD).Both isolates were resistant to ampicillin (MIC, .16mg/mL) and ceftriaxone (MIC, .32mg/mL) but susceptible to trimethoprim-sulfamethoxazole (MIC, #0.5/9.5 mg/mL).Ciprofloxacin and levofloxacin MICs were off scale on the Phoenix panel and uninterpretable by Clinical and Laboratory Standards Institute (CLSI) guidelines (1).Etest (bioMérieux, Durham, NC) MICs were 0.12 mg/mL for ciprofloxacin and 0.25 mg/mL for levofloxacin, both intermediate.The patient's clinical condition stabilized, and he was discharged after 2 days on ciprofloxacin (20 mg/kg twice a day orally) for a total course of 14 days.Serotyping at the Tennessee Department of Health revealed both blood and stool isolates were Salmonella enterica subsp.enterica serovar Infantis. DISCUSSIONNontyphoidal Salmonella (NTS) infections are a common cause of self-limiting enterocolitis and diarrhea with an estimated global incidence of 95.1 million cases annually in 2017 (2).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
- Department of Pediatrics, Division of Pediatric Infectious Diseases, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
- Department of Biomedical Engineering, Vanderbilt University, Nashville, Tennessee, USA.
- Vanderbilt Institute for Infection, Immunology, and Inflammation, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
ORCID-Profile: James E Cassat, Romney M Humphries
Zitieren
APA
Tao, L., Foster, P., Russo, C., Cassat, J. E., & Humphries, R. M. (2023). The Brief Case: Invasive Ceftriaxone-Resistant Nontyphoidal Salmonella and Antimicrobial Susceptibility Testing Considerations. Journal of Clinical Microbiology, 61(5). https://doi.org/10.1128/jcm.00750-22
Vancouver
Tao L, Foster P, Russo C, Cassat JE, Humphries RM. The Brief Case: Invasive Ceftriaxone-Resistant Nontyphoidal Salmonella and Antimicrobial Susceptibility Testing Considerations. Journal of Clinical Microbiology. 2023;61(5). doi:10.1128/jcm.00750-22
BibTeX
@article{Tao2023,
author = {Tao, Lili and Foster, Pamela and Russo, Carmella and Cassat, James E and Humphries, Romney M},
title = {The Brief Case: Invasive Ceftriaxone-Resistant Nontyphoidal Salmonella and Antimicrobial Susceptibility Testing Considerations},
journal = {Journal of Clinical Microbiology},
year = {2023},
volume = {61},
number = {5},
doi = {10.1128/jcm.00750-22}
}
EUVIMED